Shares were down around 5% on Thursday afternoon despite a beat-and-raise quarter.
Source
Related Articles
We’re reducing our cost target on Bristol Myers as 2 crucial overhangs continue
Shares were down around 5% on Thursday afternoon despite a beat-and-raise quarter.
Source